These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 7600028)

  • 1. Evaluation of the clinical TNM staging system for malignant pleural mesothelioma: an assessment in 88 patients.
    Tammilehto L; Kivisaari L; Salminen US; Maasilta P; Mattson K
    Lung Cancer; 1995 Mar; 12(1-2):25-34. PubMed ID: 7600028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The importance of surgical staging in the treatment of malignant pleural mesothelioma.
    Rusch VW; Venkatraman E
    J Thorac Cardiovasc Surg; 1996 Apr; 111(4):815-25; discussion 825-6. PubMed ID: 8614142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Prognostic Role of TNM Staging Compared With Tumor Volume and Number of Pleural Sites in Malignant Pleural Mesothelioma.
    Proto C; Signorelli D; Mallone S; Prelaj A; Lo Russo G; Imbimbo M; Galli G; Ferrara R; Ganzinelli M; Leuzzi G; Greco FG; Calareso G; Botta L; Gatta G; Garassino M; Trama A
    Clin Lung Cancer; 2019 Nov; 20(6):e652-e660. PubMed ID: 31377142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A proposed new international TNM staging system for malignant pleural mesothelioma from the International Mesothelioma Interest Group.
    Rusch VW
    Lung Cancer; 1996 Feb; 14(1):1-12. PubMed ID: 8696713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Computed tomography in the evaluation of malignant pleural mesothelioma-Association of tumor size to a sarcomatoid histology, a more advanced TNM stage and poor survival.
    Paajanen J; Laaksonen S; Ilonen I; Wolff H; Husgafvel-Pursiainen K; Kuosma E; Ollila H; Myllärniemi M; Vehmas T
    Lung Cancer; 2018 Feb; 116():73-79. PubMed ID: 29413055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specimen weight and volume: important predictors of survival in malignant pleural mesothelioma.
    Kircheva DY; Husain AN; Watson S; Kindler HL; Durkin A; Vigneswaran WT
    Eur J Cardiothorac Surg; 2016 Jun; 49(6):1642-7. PubMed ID: 26802143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of lymph node station on survival in 348 patients with surgically resected malignant pleural mesothelioma: implications for revision of the American Joint Committee on Cancer staging system.
    Flores RM; Routledge T; Seshan VE; Dycoco J; Zakowski M; Hirth Y; Rusch VW
    J Thorac Cardiovasc Surg; 2008 Sep; 136(3):605-10. PubMed ID: 18805259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A proposed new international TNM staging system for malignant pleural mesothelioma. From the International Mesothelioma Interest Group.
    Rusch VW
    Chest; 1995 Oct; 108(4):1122-8. PubMed ID: 7555126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Initial analysis of the international association for the study of lung cancer mesothelioma database.
    Rusch VW; Giroux D; Kennedy C; Ruffini E; Cangir AK; Rice D; Pass H; Asamura H; Waller D; Edwards J; Weder W; Hoffmann H; van Meerbeeck JP;
    J Thorac Oncol; 2012 Nov; 7(11):1631-9. PubMed ID: 23070243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The proposed new international TNM staging system for malignant pleural mesothelioma: application to imaging.
    Patz EF; Rusch VW; Heelan R
    AJR Am J Roentgenol; 1996 Feb; 166(2):323-7. PubMed ID: 8553940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The value of occult disease in resection margin and lymph node after extrapleural pneumonectomy for malignant mesothelioma.
    Mineo TC; Ambrogi V; Pompeo E; Baldi A; Stella F; Aurea P; Marino M
    Ann Thorac Surg; 2008 May; 85(5):1740-6. PubMed ID: 18442576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrated FDG PET-CT imaging improves staging in malignant pleural mesothelioma.
    Krüger S; Pauls S; Mottaghy FM; Buck AK; Schelzig H; Hombach V; Reske SN
    Nuklearmedizin; 2007; 46(6):239-43. PubMed ID: 18084678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epithelial malignant pleural mesothelioma after extrapleural pneumonectomy: stratification of survival with CT-derived tumor volume.
    Gill RR; Richards WG; Yeap BY; Matsuoka S; Wolf AS; Gerbaudo VH; Bueno R; Sugarbaker DJ; Hatabu H
    AJR Am J Roentgenol; 2012 Feb; 198(2):359-63. PubMed ID: 22268178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does positron emission tomography offer prognostic information in malignant pleural mesothelioma?
    Sharif S; Zahid I; Routledge T; Scarci M
    Interact Cardiovasc Thorac Surg; 2011 May; 12(5):806-11. PubMed ID: 21266493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of 18F-FDG standard uptake value by integrated PET/CT in the staging of malignant pleural mesothelioma.
    Genestreti G; Moretti A; Piciucchi S; Tiseo M; Bersanelli M; Scarlattei M; Scarpi E; Dubini A; Matteucci F; Sanna S
    Technol Cancer Res Treat; 2012 Apr; 11(2):163-7. PubMed ID: 22335410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proposed adjustments to pathologic staging of epithelial malignant pleural mesothelioma based on analysis of 354 cases.
    Richards WG; Godleski JJ; Yeap BY; Corson JM; Chirieac LR; Zellos L; Mujoomdar A; Jaklitsch MT; Bueno R; Sugarbaker DJ
    Cancer; 2010 Mar; 116(6):1510-7. PubMed ID: 20108310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Morbidity, mortality, mean survival, and the impact of histology on survival after pleurectomy in 64 patients with malignant pleural mesothelioma.
    Neragi-Miandoab S; Richards WG; Sugarbaker DJ
    Int J Surg; 2008 Aug; 6(4):293-7. PubMed ID: 18585112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative Clinical Staging for Patients With Malignant Pleural Mesothelioma.
    Gill RR; Yeap BY; Bueno R; Richards WG
    J Natl Cancer Inst; 2018 Mar; 110(3):258-264. PubMed ID: 29931180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Multicenter Study of Volumetric Computed Tomography for Staging Malignant Pleural Mesothelioma.
    Rusch VW; Gill R; Mitchell A; Naidich D; Rice DC; Pass HI; Kindler HL; De Perrot M; Friedberg J;
    Ann Thorac Surg; 2016 Oct; 102(4):1059-66. PubMed ID: 27596916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic factors in the treatment of malignant pleural mesothelioma at a large tertiary referral center.
    Flores RM; Zakowski M; Venkatraman E; Krug L; Rosenzweig K; Dycoco J; Lee C; Yeoh C; Bains M; Rusch V
    J Thorac Oncol; 2007 Oct; 2(10):957-65. PubMed ID: 17909360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.